Patent · US Active

Medical treatments based on anamorelin

US9675600B2 · kind B2 · utility

0Cited by
4References
25Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 28, 2015
Grant dateJun 13, 2017
Priority date
Expiry dateAug 28, 2035

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P39/02
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Methods of treating cancer related conditions using anamorelin are described.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.